The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...

Health Canada is supposed to issue rulings on new generics – which are copies of branded drugs whose patents have expired – ...

Importers can now apply, track, and receive approval for their drug consignments via an integrated digital portal, ...

AbbVie is seeking a new way to fight chronic lymphocytic leukemia by combining its oncology drug Venclexta with another ...

After a decade of development, a Kansas City-based pharmaceutical company is on the brink of submitting its ADHD medication ...

The new guidelines aim to streamline India’s drug approvals, improve transparency, and align regulatory practices with global ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

AbbVie submitted a supplemental new drug application for Venclexta plus Calquence treatment in previously untreated chronic ...

The program has been transitioned to a permanent pathway that is designed to support innovative tools like artificial intelligence, wearables, and biomarkers in drug development and trials.

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...

Gireesh Babu, New Delhi Tuesday, August 5, 2025, 08:00 Hrs [IST] ...

July marks a transformative month in oncology with the FDA's groundbreaking approvals and updates, enhancing treatment ...